Bio-Rad Labs (BIO) Tops Q2 EPS by 19c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $356.26 --0%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
GNLN, AFIB, USDP, More
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
GNLN, AFIB, USDP, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $0.97, $0.19 better than the analyst estimate of $0.78. Revenue for the quarter came in at $506.1 million versus the consensus estimate of $494.85 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
- Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
